From a therapeutic perspective, our study demonstrates that targeting TMEM160 in combination with conventional chemotherapy drugs such as 5-fu significantly enhances the sensitivity of GC cells to chemotherapy and inhibits tumor growth both in vitro and in vivo. The gene discussed is TMEM160; the disease is neoplasm.